Quel rôle pour le microbiome pulmonaire ?
Commentary: Lung cancer and dysbiosis: Debugging the studies for the future. Pass HI. J Thorac Cardiovasc Surg. 2021 Feb;161(2):430-431.
Commentary: Lung cancer and dysbiosis: Debugging the studies for the future. Pass HI. J Thorac Cardiovasc Surg. 2021 Feb;161(2):430-431.
Exosomes and Lung Cancer: Roles in Pathophysiology, Diagnosis and Therapeutic Applications. Amiri A et al. Curr Med Chem. 2021;28(2):308-328.
Prospective Observational Study Revealing Early Pulmonary Function Changes Associated With Brigatinib Initiation. Ng TL et al. J Thorac Oncol. 2021 Mar;16(3):486-491.
Dual EGFR-VEGF Pathway Inhibition: A Promising Strategy for Patients With EGFR-Mutant NSCLC. Le X et al. J Thorac Oncol. 2021 Feb;16(2):205-215.
Switch-maintenance gemcitabine after first-line chemotherapy in patients with malignant mesothelioma (NVALT19): an investigator-initiated, randomised, open-label, phase 2 trial. de Gooijer CJ, et al. Lancet Respir Med. 2021 Jan 27:S2213-2600(20)30362-3. [...]
Réf. : convergences.online/rhumato ; 1 (l) : U1Abemaciclib in high risk early breast cancer, présentation à l’ESMO 2020 ; Johnston et al, ESMO 2020, LBA5 PR. Données actualisées SABCS 2020 ; J. O’Shaughnessy, et [...]
Réf. : convergences.online/rhumato ; 1 (l) : R3 Autoantibodies against tumor-associated antigens in sputum as biomarkers for lung cancer ✩ Ning Li, Van K. Holden, Janaki Deepak, Nevins W. Todd, Feng Jiang ∗ Departments [...]
Réf. : convergences.online/rhumato ; 1 (l) : R2 Efficacy and Safety of Rovalpituzumab Tesirine Compared with Topotecan as Second-Line Therapy in DLL3-High Small Cell Lung Cancer: Results from the Phase 3 [...]
Réf. : convergences.online/rhumato ; 1 (l) : R1 Tobacco use as a well-recognized cause of severe COVID-19 manifestations Alpana Kumar Gupta a, Suzanne Tanya Nethan b , Ravi Mehrotra c,d,* Respiratory [...]